Medical Center

Primary Total: $52,502,661

College of Medicine

Total: $42,538,086

Primary Total: $39,077,134

Surgery

Total: $943,346

Primary Total: $510,510

W.A.Arden/D.R.Gross

*Role of Neuropeptide CGRP in Vascular Response, (429214), Natl Heart Lung and Blood Institute, $79,754.

W.E.Charash/D.P.Wermeling

*A Double-Blind, Randomized, Placebo-Controlled Study of Inhaled Nitric Oxide in the Treatment of Acute Respiratory Disease Syndrome, (429827), Ohmeda Pharmaceuticals, $2.

*A Double-Blind Randomized Placebo-Controlled Dose-Response Study of Inhaled Nitric Oxide (OHM-11771) in the Treatment of Acute Respiratory Distress Syndrome (ARDS), (428455), Ohmeda Pharmaceuticals, $77,082 (adjustment).

E.D.Endean/W.N.O'Connor

*Polyamine Regulation and Arterial Intimal Hyperplasia, (426808), Natl Heart Lung and Blood Institute, $106,722 (adjustment).

K.A.Foon/H.Kohler/T.C.Vanaman/A.M.Kaplan/G.H.Friedell/J.R.Vannagell Jr./P.C.McGrath/T.C.Meeker

*Planning Grants for Prospective Cancer Centers, (433333), Natl Cancer Institute, $76,528.

*Planning Grants for Prospective Cancer Centers, (433334), Natl Cancer Institute, $51,450.

*Planning Grants for Prospective Cancer Centers, (433332), Natl Cancer Institute, $52,013.

*Planning Grants for Prospective Cancer Centers, (429225), Natl Cancer Institute, $257,250.

*Planning Grants for Prospective Cancer Centers, (433335), Natl Cancer Institute, $8,820.

C.L.Fowler/S.Zimmer

*Role of Metalloproteinases in Neuroblastoma Metastasis, (429337), Natl Cancer Institute, $75,582.

J.W.Freeman/P.C.McGrath

Clinical Significance of P120 in Breast Cancer, (429609), American Cancer Society, $200,000.

G.L.Hyde/M.J.Buckmaster/C.S.Kuo

*Balloon Angioscope-Development of Aortic Balloon Angioscope and Endovascular Aortic Graft Delivery System, (428838), Baxter Healthcare Co, $40,000 (adjustment).

P.A.Kearney/D.P.Wermeling

*Randomized, Placebo-Controlled Trial of MAK 195F in Sepais with Hyperinflammatory Response, (429751), Knoll Pharmaceutical Company, $11,001.

*A Trial to Evaluate the Efficacy and Safety of Two Doses of Lexipafant for the Treatment of Acute Pancreatitis, (429908), British Biotech Inc, $2.

K.Pugh/J.Gorczyca

*Biomechanical Testing of Subtrochanteric Femur Fracture Fixation, (429614), Zimmer Inc, $6,918.

E.H.Romond/D.E.Kenady

*Cooperative Group for Breast and Colorectal Clinical Trials, (429717), Natl Cancer Institute, $4,995 (adjustment).

*Cooperative Group for Breast and Colorectal Clinical Trials, (433369), Natl Cancer Institute, $4,995 (adjustment).

R.W.Schwartz/D.P.Wermeling

*Comparison of the Safety, Efficacy and Economic Impact of Sequential (IV to PO) Ciprofloxacin Plus Metronidazole with Piperacillin/Tazobactam for the Treatment of Patients with Complicated Intraabdominal Infection, (429983), Bayer Pharmaceuticals, $2.

D.A.Sloan

Breast Cancer Education Initiatives, (428468), Natl Cancer Institute, $84,034 (adjustment).

D.P.Wermeling/W.E.Strodel

*An Open Study to Investigate the Biliary Excretion of L-748, 731 and its Metabolites Following Single Oral Doses of C-L-748, 731 in Patients Having a Surgically Implanted T-Tube, (429693), Merck and Company Inc, $2.

Return to College of Medicine Departmental Listing

Return to Medical Center College Listing

Return to Top

Questions:

For questions regarding listings, contact Ms. Deborah Davis, director of the Office of Sponsored Projects Administration, 214 Kinkead Hall, 0057, phone 257-8311. (ddavis@pop.uky.edu )

Last Updated: 6/30/03